SEARCH

SEARCH BY CITATION

References

  • 1
    Murphy DJ, Stirrat GM. Mortality and morbidity associated with early-onset preeclampsia. Hypertens Pregnancy 2000;19:22131.
  • 2
    Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:10006.
  • 3
    Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986;155:5019.
  • 4
    Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at below 28.0 weeks’ gestation. Am J Obstet Gynecol 2000;183:14759.
  • 5
    Sibai BM. Prevention of preeclampsia: a big disappointment. Am J Obstet Gynecol 1998;179:12758.
  • 6
    Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 1996;175:136570.
  • 7
    Hall DR, Odendaal HJ, Kirsten GF, Smith J, Grove D. Expectant management of early onset, severe pre-eclampsia: perinatal outcome. BJOG 2000;107:125864.
  • 8
    Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks’ gestation: a randomized controlled trial. Obstet Gynecol 1990;76:10705.
  • 9
    Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks’ gestation: a randomized controlled trial. Am J Obstet Gynecol 1994;171:81822.
  • 10
    Hall DR, Odendaal HJ, Steyn DW, Grove D. Expectant management of early onset, severe pre-eclampsia: maternal outcome. BJOG 2000;107:12527.
  • 11
    Visser W, Wallenburg HC. Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from term. Eur J Obstet Gynecol Reprod Biol 1995;63:14754.
  • 12
    Van Pampus MG, Wolf H, Westenberg SM, Van der Post JA, Bonsel GJ, Treffers PE. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 1998;76:316.
  • 13
    Van Pampus MG, Wolf H, Ilsen A, Treffers PE. Maternal outcome following temporizing management of the (H)ELLP syndrome. Hypertens Pregnancy 2000;19:21120.
  • 14
    Ganzevoort W, Rep A, De Vries JI, Bonsel GJ, Wolf H. Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early onset severe hypertensive disorders of pregnancy. Am J Obstet Gynecol 2006;195:495503.
  • 15
    Withagen MIJ, Visser W, Wallenburg HCS. Neonatal outcome of temporizing treatment in early-onset preeclampsia. Eur J Obstet Gynecol Reprod Biol 2001;94:21115.
  • 16
    Witlin AG, Saade GR, Mattar F, Sibai BM. Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks’ gestation. Am J Obstet Gynecol 2000;182:60711.
  • 17
    Ganzevoort W, Rep A, Bonsel GJ, De Vries JI, Wolf H. A randomized trial of plasma volume expansion in hypertensive disorders of pregnancy: influence on the pulsatility indices of the fetal umbilical artery and middle cerebral artery. Am J Obstet Gynecol 2005;192:2339.
  • 18
    Ganzevoort W, Rep A, Bonsel GJ, Fetter WPF, Van Sonderen L, De Vries JIP, et al. A randomised controlled trial comparing a temporising management strategy with plasma volume expansion with one without plasma volume expansion. BJOG 2005;112:135868.
  • 19
    Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:8928.
  • 20
    Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 1990;162:31116.
  • 21
    Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customised antenatal growth charts. Lancet 1992;339:2837.
  • 22
    Ganzevoort JW, Hoogerwaard EM, Van der Post JA. Hypocalcemic delirium due to magnesium sulphate therapy in a pregnant woman with pre-eclampsia. Ned Tijdschr Geneeskd 2002;146:14536.
  • 23
    Visser W, Wallenburg HC. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 1995;102:11117.
  • 24
    Chard T, Penney G, Chalmers J. The risk of neonatal death in relation to birth weight and maternal hypertensive disease in infants born at 24-32 weeks. Eur J Obstet Gynecol Reprod Biol 2001;95:11418.